Department of Oncology, Rigshospitalet, Copenhagen
Drug development has been in focus at the Department of Oncology for more than 25 years. In recent years, the technical demands of early clinical trials have increased. As a consequence, the department has opened a dedicated unit for Phase I and early Phase II trials.
We offer complete project management and clinical trial management systems.
We are operating with ICH GCP to industry standards, including standard operating procedures (SOPs) covering all aspects of running clinical trials.
We comply with all current legal requirements and the needs of the EU Directive on Clinical Trials (Directive 2001/20/EC).
Phase I Unit
Department of Oncology, 5011The Finsen Centre, RigshospitaletBlegdamsvej 9 DK-2100CopenhagenDenmark
Phone: +45 35454958
Fax: +45 35454391
Medical experts from Copenhagen University Hospital Rigshospitalet have in collaboration with international colleagues developed European guidelines on how to handle abnormal uterine bleeding during and after menopause aiming inter alia to reduce the number of unnecessary uterine Dilatation and Curettage (D&C) procedures.
One thing is to have state-of-the-art scanners; another thing is to decode the scan images. Rigshospitalet was one of the first hospitals in Europe to acquire an ultra-fast CT scanner. The hospital is now teaching physicians from all over the world to read scans of the heart.
Measurable effects of prioritised and focussed health and safety initiatives only come after implementation; transforming words into action in daily routines. This is what makes a winner and it is on this basis that Rigshospitalet received the European Good Practice Award in April 2013.